New CGM system aims to improve blood sugar control in diabetes patients
Disease control
ENROLLING_BY_INVITATION
This study is testing a new continuous glucose monitor (CGM) called iCan O3 in 70 adults with type 1 or type 2 diabetes. Participants will wear the device for 60 days to see if it helps them keep their blood sugar in a healthy range more often. The goal is to improve diabetes con…
Phase: NA • Sponsor: Sinocare • Aim: Disease control
Last updated May 03, 2026 11:29 UTC